BVF INC/IL Holdings

BVF INC/IL is an investment fund managing more than 2.42B US dollars. The largest holdings include MoonLake Immunotherapeutics, Ionis Pharmaceuticals and GH Research. In Q3 2022 the fund bought assets of total value of 341.58M US dollars and sold assets of total value of 63.65M US dollars.

$2.42B

portfolio value

+9.53%

quarter

-40.34%

1 year

-13.10%

3 years

-13.21%

5 years

BVF INC/IL portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	-95557000	50702000
Q2 2016	108389000	38612000
Q3 2016	67469000	1018000
Q4 2016	27190000	42715000
Q1 2017	153863000	36565000
Q2 2017	88909000	75990000
Q3 2017	168230000	45898000
Q4 2017	146065000	145634000
Q1 2018	220939000	18599000
Q2 2018	225772000	169247000
Q3 2018	164054000	29532000
Q4 2018	-74202000	219559000
Q1 2019	141543000	66152000
Q2 2019	155068000	89298000
Q3 2019	224450000	98477000
Q4 2019	521326000	175455000
Q1 2020	126433000	232428000
Q2 2020	624044000	85435000
Q3 2020	451961000	189001000
Q4 2020	791421000	321599000
Q1 2021	643487000	310605000
Q2 2021	535713000	239527000
Q3 2021	370941000	365908000
Q4 2021	437920000	180800000
Q1 2022	133542000	205498000
Q2 2022	195261000	398402000
Q3 2022	341579000	63647000

BVF INC/IL 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology MoonLake Immunotherapeutics Portfolio share: 7.15% Portfolio value: 173.14M Avg. open price: N/A Current price: $10.07 P/L: N/A N/A Q2 2022	share	7.15%	173.14M	N/A	$10.07	N/A	N/A Q2 2022
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 5.25% Portfolio value: 127.07M Avg. open price: $47.12 Current price: $38.98 P/L: -17.27% Bought +125.05% shares Q3 2022	share	5.25%	127.07M	$47.12	$38.98	-17.27%	Bought +125.05% shares Q3 2022
Biotechnology GH Research PLC Portfolio share: 4.45% Portfolio value: 107.77M Avg. open price: $21.73 Current price: $11.4 P/L: -47.54% Bought 0.00% shares Q3 2021	share	4.45%	107.77M	$21.73	$11.4	-47.54%	Bought 0.00% shares Q3 2021
Biotechnology Kymera Therapeutics, Inc. Portfolio share: 4.22% Portfolio value: 102.15M Avg. open price: $41.96 Current price: $29.11 P/L: -30.62% Bought +13.38% shares Q3 2022	share	4.22%	102.15M	$41.96	$29.11	-30.62%	Bought +13.38% shares Q3 2022
Biotechnology Repare Therapeutics Inc. Portfolio share: 4.15% Portfolio value: 100.58M Avg. open price: $22.7 Current price: $16.49 P/L: -27.36% Bought +41.53% shares Q2 2022	share	4.15%	100.58M	$22.7	$16.49	-27.36%	Bought +41.53% shares Q2 2022
Biotechnology Relay Therapeutics, Inc. Portfolio share: 4.01% Portfolio value: 97.07M Avg. open price: $31.57 Current price: $18.36 P/L: -41.85% Sold -1.03% shares Q3 2022	share	4.01%	97.07M	$31.57	$18.36	-41.85%	Sold -1.03% shares Q3 2022
Biotechnology Cullinan Oncology, Inc. Portfolio share: 3.98% Portfolio value: 96.26M Avg. open price: $18.75 Current price: $11.61 P/L: -38.07% Bought +39.85% shares Q2 2022	share	3.98%	96.26M	$18.75	$11.61	-38.07%	Bought +39.85% shares Q2 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 3.18% Portfolio value: 76.93M Avg. open price: $19.21 Current price: $4.45 P/L: -76.83% Bought +25.25% shares Q3 2022	share	3.18%	76.93M	$19.21	$4.45	-76.83%	Bought +25.25% shares Q3 2022
Biotechnology Crinetics Pharmaceuticals, Inc. Portfolio share: 2.98% Portfolio value: 72.25M Avg. open price: $20.66 Current price: $18.32 P/L: -11.31% Bought +22.47% shares Q2 2022	share	2.98%	72.25M	$20.66	$18.32	-11.31%	Bought +22.47% shares Q2 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 2.94% Portfolio value: 71.07M Avg. open price: $19.81 Current price: $33.96 P/L: +71.46% Sold -31.40% shares Q3 2022	share	2.94%	71.07M	$19.81	$33.96	+71.46%	Sold -31.40% shares Q3 2022
Biotechnology Merus N.V. Portfolio share: 2.85% Portfolio value: 68.99M Avg. open price: $16.12 Current price: $14.2 P/L: -11.93% Sold -15.61% shares Q3 2022	share	2.85%	68.99M	$16.12	$14.2	-11.93%	Sold -15.61% shares Q3 2022
Biotechnology Third Harmonic Bio, Inc. Portfolio share: 2.74% Portfolio value: 66.42M Avg. open price: N/A Current price: $22 P/L: N/A N/A Q3 2022	share	2.74%	66.42M	N/A	$22	N/A	N/A Q3 2022
Biotechnology XOMA Corporation Portfolio share: 2.67% Portfolio value: 64.68M Avg. open price: $15.33 Current price: $19.65 P/L: +28.19% Bought +2.29% shares Q3 2022	share	2.67%	64.68M	$15.33	$19.65	+28.19%	Bought +2.29% shares Q3 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 2.65% Portfolio value: 64.2M Avg. open price: $28.44 Current price: $24.32 P/L: -14.50% Bought +44.33% shares Q3 2022	share	2.65%	64.2M	$28.44	$24.32	-14.50%	Bought +44.33% shares Q3 2022
Diagnostics & Research Aclaris Therapeutics, Inc. Portfolio share: 2.59% Portfolio value: 62.59M Avg. open price: $15.13 Current price: $15.66 P/L: +3.48% Bought +134.48% shares Q1 2022	share	2.59%	62.59M	$15.13	$15.66	+3.48%	Bought +134.48% shares Q1 2022
Biotechnology CTI BioPharma Corp. Portfolio share: 2.12% Portfolio value: 51.29M Avg. open price: $3.92 Current price: $5.61 P/L: +43.28% Sold -1.31% shares Q3 2022	share	2.12%	51.29M	$3.92	$5.61	+43.28%	Sold -1.31% shares Q3 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 2.03% Portfolio value: 49.15M Avg. open price: $7.77 Current price: $17.77 P/L: +128.61% Bought +17.89% shares Q3 2022	share	2.03%	49.15M	$7.77	$17.77	+128.61%	Bought +17.89% shares Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 1.81% Portfolio value: 43.76M Avg. open price: $17.36 Current price: $15.82 P/L: -8.89% Bought +55.21% shares Q1 2022	share	1.81%	43.76M	$17.36	$15.82	-8.89%	Bought +55.21% shares Q1 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 1.78% Portfolio value: 43.21M Avg. open price: $6.63 Current price: $6.72 P/L: +1.37% Bought +65.98% shares Q3 2022	share	1.78%	43.21M	$6.63	$6.72	+1.37%	Bought +65.98% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 1.78% Portfolio value: 43.20M Avg. open price: $17.5 Current price: $25.44 P/L: +45.33% Sold -23.71% shares Q3 2022	share	1.78%	43.20M	$17.5	$25.44	+45.33%	Sold -23.71% shares Q3 2022
Biotechnology CinCor Pharma, Inc. Portfolio share: 1.78% Portfolio value: 43.07M Avg. open price: N/A Current price: $12.33 P/L: N/A Sold -20.19% shares Q3 2022	share	1.78%	43.07M	N/A	$12.33	N/A	Sold -20.19% shares Q3 2022
Biotechnology Lexicon Pharmaceuticals, Inc. Portfolio share: 1.60% Portfolio value: 38.75M Avg. open price: $3.9 Current price: $2.16 P/L: -44.68% Bought +14.14% shares Q3 2022	share	1.60%	38.75M	$3.9	$2.16	-44.68%	Bought +14.14% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 1.48% Portfolio value: 35.72M Avg. open price: $17 Current price: $26.84 P/L: +57.92% Sold -0.12% shares Q3 2022	share	1.48%	35.72M	$17	$26.84	+57.92%	Sold -0.12% shares Q3 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 1.43% Portfolio value: 34.49M Avg. open price: $32.18 Current price: $20.04 P/L: -37.73% Sold -6.14% shares Q3 2022	share	1.43%	34.49M	$32.18	$20.04	-37.73%	Sold -6.14% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 1.34% Portfolio value: 32.53M Avg. open price: $10.45 Current price: $38.83 P/L: +271.48% Sold -43.61% shares Q3 2022	share	1.34%	32.53M	$10.45	$38.83	+271.48%	Sold -43.61% shares Q3 2022
Biotechnology Nuvalent, Inc. Portfolio share: 1.34% Portfolio value: 32.39M Avg. open price: $14.94 Current price: $34.16 P/L: +128.61% Bought +141.69% shares Q2 2022	share	1.34%	32.39M	$14.94	$34.16	+128.61%	Bought +141.69% shares Q2 2022
Biotechnology 4D Molecular Therapeutics, Inc. Portfolio share: 1.33% Portfolio value: 32.22M Avg. open price: $25.87 Current price: $23.17 P/L: -10.43% Bought +50.40% shares Q2 2022	share	1.33%	32.22M	$25.87	$23.17	-10.43%	Bought +50.40% shares Q2 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 1.28% Portfolio value: 31.10M Avg. open price: $7.49 Current price: $12.5 P/L: +66.89% Sold -7.64% shares Q3 2022	share	1.28%	31.10M	$7.49	$12.5	+66.89%	Sold -7.64% shares Q3 2022
Biotechnology Allakos Inc. Portfolio share: 1.27% Portfolio value: 30.64M Avg. open price: N/A Current price: $8.14 P/L: N/A N/A Q3 2022	share	1.27%	30.64M	N/A	$8.14	N/A	N/A Q3 2022
Biotechnology EQRx, Inc. Portfolio share: 1.23% Portfolio value: 29.74M Avg. open price: $6.57 Current price: $3.46 P/L: -47.34% Sold -43.58% shares Q3 2022	share	1.23%	29.74M	$6.57	$3.46	-47.34%	Sold -43.58% shares Q3 2022
Biotechnology AN2 Therapeutics, Inc. Portfolio share: 1.16% Portfolio value: 28.09M Avg. open price: N/A Current price: $9.14 P/L: N/A N/A Q1 2022	share	1.16%	28.09M	N/A	$9.14	N/A	N/A Q1 2022
Biotechnology Centessa Pharmaceuticals plc Portfolio share: 1.14% Portfolio value: 27.71M Avg. open price: $9.53 Current price: $3.93 P/L: -58.77% Bought +292.72% shares Q2 2022	share	1.14%	27.71M	$9.53	$3.93	-58.77%	Bought +292.72% shares Q2 2022
Biotechnology Concert Pharmaceuticals, Inc. Portfolio share: 1.00% Portfolio value: 24.31M Avg. open price: $10.47 Current price: $4.76 P/L: -54.54% Bought +61.07% shares Q2 2022	share	1.00%	24.31M	$10.47	$4.76	-54.54%	Bought +61.07% shares Q2 2022
Biotechnology AC Immune SA Portfolio share: 0.97% Portfolio value: 23.47M Avg. open price: $7.56 Current price: $2.42 P/L: -67.97% Bought +5.18% shares Q1 2022	share	0.97%	23.47M	$7.56	$2.42	-67.97%	Bought +5.18% shares Q1 2022
Biotechnology Annexon, Inc. Portfolio share: 0.97% Portfolio value: 23.36M Avg. open price: N/A Current price: $5.74 P/L: N/A N/A Q2 2022	share	0.97%	23.36M	N/A	$5.74	N/A	N/A Q2 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 0.92% Portfolio value: 22.32M Avg. open price: N/A Current price: $21.42 P/L: N/A N/A Q3 2022	share	0.92%	22.32M	N/A	$21.42	N/A	N/A Q3 2022
Biotechnology Tyra Biosciences, Inc. Portfolio share: 0.90% Portfolio value: 21.73M Avg. open price: $14.77 Current price: $6.89 P/L: -53.35% Bought +31.97% shares Q1 2022	share	0.90%	21.73M	$14.77	$6.89	-53.35%	Bought +31.97% shares Q1 2022
Biotechnology Olema Pharmaceuticals, Inc. Portfolio share: 0.87% Portfolio value: 21.00M Avg. open price: $22.65 Current price: $2.79 P/L: -87.68% Bought +2.70% shares Q2 2022	share	0.87%	21.00M	$22.65	$2.79	-87.68%	Bought +2.70% shares Q2 2022
Biotechnology Janux Therapeutics, Inc. Portfolio share: 0.82% Portfolio value: 19.90M Avg. open price: $15.87 Current price: $13.5 P/L: -14.94% Bought +28.71% shares Q2 2022	share	0.82%	19.90M	$15.87	$13.5	-14.94%	Bought +28.71% shares Q2 2022
Biotechnology Sutro Biopharma, Inc. Portfolio share: 0.79% Portfolio value: 19.13M Avg. open price: $12.34 Current price: $7.39 P/L: -40.10% Bought +272.69% shares Q1 2022	share	0.79%	19.13M	$12.34	$7.39	-40.10%	Bought +272.69% shares Q1 2022
Biotechnology 89bio, Inc. Portfolio share: 0.75% Portfolio value: 18.20M Avg. open price: N/A Current price: $8.34 P/L: N/A Sold -19.35% shares Q3 2022	share	0.75%	18.20M	N/A	$8.34	N/A	Sold -19.35% shares Q3 2022
Biotechnology Rain Therapeutics Inc. Portfolio share: 0.71% Portfolio value: 17.21M Avg. open price: $14.39 Current price: $6.83 P/L: -52.54% Bought +19.23% shares Q1 2022	share	0.71%	17.21M	$14.39	$6.83	-52.54%	Bought +19.23% shares Q1 2022
Biotechnology Verastem, Inc. Portfolio share: 0.70% Portfolio value: 16.97M Avg. open price: $2.97 Current price: $0.42 P/L: -85.87% Bought +17.07% shares Q1 2022	share	0.70%	16.97M	$2.97	$0.42	-85.87%	Bought +17.07% shares Q1 2022
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 0.68% Portfolio value: 16.50M Avg. open price: N/A Current price: $12 P/L: N/A N/A Q3 2022	share	0.68%	16.50M	N/A	$12	N/A	N/A Q3 2022
Biotechnology Replimune Group, Inc. Portfolio share: 0.66% Portfolio value: 16.00M Avg. open price: $15.65 Current price: $19.95 P/L: +27.51% Bought +0.83% shares Q3 2021	share	0.66%	16.00M	$15.65	$19.95	+27.51%	Bought +0.83% shares Q3 2021
Biotechnology ESSA Pharma Inc. Portfolio share: 0.66% Portfolio value: 15.92M Avg. open price: $5.57 Current price: $3.47 P/L: -37.70% Bought +136.54% shares Q3 2022	share	0.66%	15.92M	$5.57	$3.47	-37.70%	Bought +136.54% shares Q3 2022
Biotechnology Viracta Therapeutics, Inc. Portfolio share: 0.64% Portfolio value: 15.43M Avg. open price: $6.62 Current price: $2.15 P/L: -67.50% Bought +5.11% shares Q1 2022	share	0.64%	15.43M	$6.62	$2.15	-67.50%	Bought +5.11% shares Q1 2022
Biotechnology Silence Therapeutics plc Portfolio share: 0.61% Portfolio value: 14.88M Avg. open price: $11.85 Current price: $17.09 P/L: +44.22% Bought +126.26% shares Q3 2022	share	0.61%	14.88M	$11.85	$17.09	+44.22%	Bought +126.26% shares Q3 2022
Biotechnology Ovid Therapeutics Inc. Portfolio share: 0.52% Portfolio value: 12.60M Avg. open price: $4.1 Current price: $1.79 P/L: -56.33% Bought +3.32% shares Q1 2022	share	0.52%	12.60M	$4.1	$1.79	-56.33%	Bought +3.32% shares Q1 2022
Biotechnology Aadi Bioscience, Inc. Portfolio share: 0.51% Portfolio value: 12.42M Avg. open price: N/A Current price: $13.42 P/L: N/A Sold -2.26% shares Q1 2022	share	0.51%	12.42M	N/A	$13.42	N/A	Sold -2.26% shares Q1 2022
Biotechnology Calliditas Therapeutics AB (publ) Portfolio share: 0.47% Portfolio value: 11.32M Avg. open price: N/A Current price: $18.21 P/L: N/A N/A Q2 2020	share	0.47%	11.32M	N/A	$18.21	N/A	N/A Q2 2020
Biotechnology CytomX Therapeutics, Inc. Portfolio share: 0.40% Portfolio value: 9.56M Avg. open price: $8.31 Current price: $1.71 P/L: -79.42% Bought +13.65% shares Q3 2022	share	0.40%	9.56M	$8.31	$1.71	-79.42%	Bought +13.65% shares Q3 2022
Biotechnology Ikena Oncology, Inc. Portfolio share: 0.37% Portfolio value: 8.88M Avg. open price: $15.95 Current price: $2.23 P/L: -86.02% Bought +0.06% shares Q2 2022	share	0.37%	8.88M	$15.95	$2.23	-86.02%	Bought +0.06% shares Q2 2022
Biotechnology Alpine Immune Sciences, Inc. Portfolio share: 0.34% Portfolio value: 8.17M Avg. open price: $3.68 Current price: $6.78 P/L: +84.10% Sold -10.92% shares Q3 2022	share	0.34%	8.17M	$3.68	$6.78	+84.10%	Sold -10.92% shares Q3 2022
Biotechnology Infinity Pharmaceuticals, Inc. Portfolio share: 0.31% Portfolio value: 7.56M Avg. open price: $1.97 Current price: $0.55 P/L: -71.91% Sold -24.21% shares Q4 2021	share	0.31%	7.56M	$1.97	$0.55	-71.91%	Sold -24.21% shares Q4 2021
Biotechnology HilleVax, Inc. Portfolio share: 0.27% Portfolio value: 6.53M Avg. open price: N/A Current price: $17.5 P/L: N/A Sold -0.02% shares Q3 2022	share	0.27%	6.53M	N/A	$17.5	N/A	Sold -0.02% shares Q3 2022
Biotechnology Eledon Pharmaceuticals, Inc. Portfolio share: 0.27% Portfolio value: 6.42M Avg. open price: $5.11 Current price: $2.43 P/L: -52.48% Bought +68.84% shares Q1 2022	share	0.27%	6.42M	$5.11	$2.43	-52.48%	Bought +68.84% shares Q1 2022
Biotechnology Pieris Pharmaceuticals, Inc. Portfolio share: 0.24% Portfolio value: 5.84M Avg. open price: $4.34 Current price: $0.99 P/L: -77.22% Sold -4.65% shares Q2 2022	share	0.24%	5.84M	$4.34	$0.99	-77.22%	Sold -4.65% shares Q2 2022
Biotechnology Pyxis Oncology, Inc. Portfolio share: 0.24% Portfolio value: 5.79M Avg. open price: $10.43 Current price: $1.29 P/L: -87.63% Bought +2.69% shares Q2 2022	share	0.24%	5.79M	$10.43	$1.29	-87.63%	Bought +2.69% shares Q2 2022
Biotechnology GlycoMimetics, Inc. Portfolio share: 0.22% Portfolio value: 5.26M Avg. open price: $4.38 Current price: $2.25 P/L: -48.66% Bought +31.75% shares Q4 2020	share	0.22%	5.26M	$4.38	$2.25	-48.66%	Bought +31.75% shares Q4 2020
Biotechnology Cidara Therapeutics, Inc. Portfolio share: 0.18% Portfolio value: 4.30M Avg. open price: $2.97 Current price: $0.6 P/L: -79.77% Bought +43.63% shares Q4 2021	share	0.18%	4.30M	$2.97	$0.6	-79.77%	Bought +43.63% shares Q4 2021
Biotechnology Spero Therapeutics, Inc. Portfolio share: 0.16% Portfolio value: 3.85M Avg. open price: $11.32 Current price: $1.89 P/L: -83.31% Sold -37.55% shares Q3 2022	share	0.16%	3.85M	$11.32	$1.89	-83.31%	Sold -37.55% shares Q3 2022
Biotechnology Molecular Templates, Inc. Portfolio share: 0.15% Portfolio value: 3.74M Avg. open price: $5.39 Current price: $0.5 P/L: -90.81% Bought +23.47% shares Q2 2022	share	0.15%	3.74M	$5.39	$0.5	-90.81%	Bought +23.47% shares Q2 2022
Biotechnology Molecular Partners AG Portfolio share: 0.12% Portfolio value: 2.97M Avg. open price: $19.61 Current price: $6.82 P/L: -65.22% Bought +5.78% shares Q4 2021	share	0.12%	2.97M	$19.61	$6.82	-65.22%	Bought +5.78% shares Q4 2021
Biotechnology Inventiva S.A. Portfolio share: 0.11% Portfolio value: 2.65M Avg. open price: $13.68 Current price: $4.45 P/L: -67.47% Bought +25.99% shares Q1 2022	share	0.11%	2.65M	$13.68	$4.45	-67.47%	Bought +25.99% shares Q1 2022
Biotechnology Elevation Oncology, Inc. Portfolio share: 0.11% Portfolio value: 2.61M Avg. open price: $5.82 Current price: $0.95 P/L: -83.68% Bought 0.00% shares Q2 2022	share	0.11%	2.61M	$5.82	$0.95	-83.68%	Bought 0.00% shares Q2 2022
Biotechnology Selecta Biosciences, Inc. Portfolio share: 0.09% Portfolio value: 2.28M Avg. open price: $2.79 Current price: $1.31 P/L: -53.09% Sold -19.23% shares Q3 2022	share	0.09%	2.28M	$2.79	$1.31	-53.09%	Sold -19.23% shares Q3 2022
Biotechnology Generation Bio Co. Portfolio share: 0.08% Portfolio value: 1.92M Avg. open price: $7.13 Current price: $5.22 P/L: -26.79% Sold -76.75% shares Q3 2022	share	0.08%	1.92M	$7.13	$5.22	-26.79%	Sold -76.75% shares Q3 2022
Biotechnology Forward Pharma A/S Portfolio share: 0.06% Portfolio value: 1.51M Avg. open price: $23.42 Current price: $2.81 P/L: -88.00% Bought +18.69% shares Q2 2022	share	0.06%	1.51M	$23.42	$2.81	-88.00%	Bought +18.69% shares Q2 2022
Biotechnology X4 Pharmaceuticals, Inc. Portfolio share: 0.06% Portfolio value: 1.45M Avg. open price: $10.57 Current price: $1.29 P/L: -87.79% Sold -22.33% shares Q2 2021	share	0.06%	1.45M	$10.57	$1.29	-87.79%	Sold -22.33% shares Q2 2021
Biotechnology Calithera Biosciences, Inc. Portfolio share: 0.06% Portfolio value: 1.36M Avg. open price: $4.04 Current price: $1.86 P/L: -53.92% N/A Q2 2022	share	0.06%	1.36M	$4.04	$1.86	-53.92%	N/A Q2 2022
Biotechnology MEI Pharma, Inc. Portfolio share: 0.06% Portfolio value: 1.36M Avg. open price: $1.68 Current price: $0.39 P/L: -76.72% Sold -1.56% shares Q2 2021	share	0.06%	1.36M	$1.68	$0.39	-76.72%	Sold -1.56% shares Q2 2021
Biotechnology Corvus Pharmaceuticals, Inc. Portfolio share: 0.05% Portfolio value: 1.12M Avg. open price: $6.01 Current price: $1 P/L: -83.36% Sold -62.73% shares Q3 2021	share	0.05%	1.12M	$6.01	$1	-83.36%	Sold -62.73% shares Q3 2021
Biotechnology Aileron Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 1.08M Avg. open price: N/A Current price: $2.79 P/L: N/A N/A Q1 2021	share	0.04%	1.08M	N/A	$2.79	N/A	N/A Q1 2021
Biotechnology Angion Biomedica Corp. Portfolio share: 0.04% Portfolio value: 986K Avg. open price: $17.17 Current price: $0.84 P/L: -95.11% Bought +3.36% shares Q3 2021	share	0.04%	986K	$17.17	$0.84	-95.11%	Bought +3.36% shares Q3 2021
Biotechnology ERYTECH Pharma S.A. Portfolio share: 0.03% Portfolio value: 690K Avg. open price: $7.04 Current price: $0.59 P/L: -91.60% Bought +110.34% shares Q2 2021	share	0.03%	690K	$7.04	$0.59	-91.60%	Bought +110.34% shares Q2 2021
Biotechnology Bionomics Limited Portfolio share: 0.02% Portfolio value: 578K Avg. open price: N/A Current price: $6.9 P/L: N/A N/A Q4 2021	share	0.02%	578K	N/A	$6.9	N/A	N/A Q4 2021
Biotechnology Galmed Pharmaceuticals Ltd. Portfolio share: 0.02% Portfolio value: 558K Avg. open price: $13.58 Current price: $0.32 P/L: -97.67% Sold -1.79% shares Q2 2020	share	0.02%	558K	$13.58	$0.32	-97.67%	Sold -1.79% shares Q2 2020
Biotechnology Rezolute, Inc. Portfolio share: 0.02% Portfolio value: 523K Avg. open price: $11.99 Current price: $1.71 P/L: -85.74% Bought 0.00% shares Q1 2021	share	0.02%	523K	$11.99	$1.71	-85.74%	Bought 0.00% shares Q1 2021
Biotechnology ContraFect Corporation Portfolio share: 0.00% Portfolio value: 79K Avg. open price: $5.12 Current price: $0.14 P/L: -97.21% Sold -88.11% shares Q3 2022	share	0.00%	79K	$5.12	$0.14	-97.21%	Sold -88.11% shares Q3 2022
Biotechnology Voyager Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $2.86 Current price: $6.27 P/L: +119.23% Sold -100.00% shares Q3 2022	share	0.00%	0	$2.86	$6.27	+119.23%	Sold -100.00% shares Q3 2022
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $14.11 Current price: $7.8 P/L: -44.73% Sold -100.00% shares Q3 2022	share	0.00%	0	$14.11	$7.8	-44.73%	Sold -100.00% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $13 Current price: $36.66 P/L: +182.00% Sold -100.00% shares Q3 2022	share	0.00%	0	$13	$36.66	+182.00%	Sold -100.00% shares Q3 2022

Showing TOP 83 BVF INC/IL's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of BVF INC/IL?

The biggest position of the BVF INC/IL is MoonLake Immunotherapeutics (MLTX) with 7.15% portfolio share worth of 173.14M US dollars.

Top 5 BVF INC/IL's holdings represent 25.23% of the portfolio:

MoonLake Immunotherapeutics (MLTX) – 7.15%
Ionis Pharmaceuticals, Inc. (IONS) – 5.25%
GH Research PLC (GHRS) – 4.45%
Kymera Therapeutics, Inc. (KYMR) – 4.22%
Repare Therapeutics Inc. (RPTX) – 4.15%

Who is the portfolio manager of BVF INC/IL?

The portfolio manager of the BVF INC/IL is .

What is the total asset value of the BVF INC/IL portfolio?

BVF INC/IL total asset value (portfolio value) is 2.42B US dollars.

Who is ?

is the portfolio manager of the BVF INC/IL.

What is (BVF INC/IL) fund performance?

BVF INC/IL's quarterly performance is +9.53%, annualy -40.34%. In the past 3 years, the value of 's portfolio has decreased by -13%. In the past 5 years, the value of the portfolio has decreased by -13%.

What is the BVF INC/IL CIK?

BVF INC/IL's Central Index Key is 0001056807 .

BVF INC/IL Holdings

BVF INC/IL portfolio value:

BVF INC/IL quarter portfolio value change:

BVF INC/IL 1 year portfolio value change:

BVF INC/IL 3 years portfolio value change:

BVF INC/IL 5 years portfolio value change: